Showing 381-390 of 1560 results for "".
Pharmacology of Emerging Selective Sodium Channel Antagonists for the Treatment of Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/pharmacology-of-emerging-selective-sodium-channel-antagonists-for-the-treatment-of-epilepsy/39904/The development of isoform-selective sodium channel inhibitors that spare GABAergic interneuron function is in its early stages but holds promise as an exciting area of research.Intermittent Calorie Restriction Alters Immune and Metabolic Markers in RRMS
https://reachmd.com/programs/neurofrontiers/Intermittent-Calorie-Restriction-Alters-Immune-and-Metabolic-Markers-in-Relapsing-Remitting-Multiple-Sclerosis/36352/The Modern Mature Woman
https://modernaesthetics.com/ma-issues-index/july-august-2025/modern-mature-woman-navigating-skincare-style-refine-not-redo/36654/Navigating skincare and style to refine, not redoSjögren’s Disease Management: A Decade in Review
https://reachmd.com/programs/living-rheum/sjogrens-disease-management-a-decade-in-review/36342/Board Forum: Hope and Skepticism in the Aesthetics Pipeline
https://modernaesthetics.com/topics/practice-development/board-forum-hope-and-skepticism-in-the-aesthetics-pipeline/35191/Insights on a Noninvasive Treatment Option for mNSCLC with Progression On or After a Platinum-Based Regimen
https://reachmd.com/programs/medical-industry-feature/insights-on-a-noninvasive-treatment-option-for-mnsclc-with-progression-on-or-after-a-platinum-based-regimen/24485/DOR/ISL Two-Drug Regimen for HIV-1 Is Non-Inferior to BIC/FTC/TAF
https://reachmd.com/programs/clinicians-roundtable/dorisl-two-drug-regimen-for-hiv-1-is-non-inferior-to-bicftctaf/32856/Antibody-Drug Conjugates: An Emerging Approach in NSCLC Treatment
https://reachmd.com/programs/project-oncology/antibody-drug-conjugates-an-emerging-approach-in-nsclc-treatment/16363/What role might antibody-drug conjugates have on the therapeutic approach to NSCLC? Find out.Personalizing Care Within the RCC Treatment Paradigm
https://reachmd.com/programs/cme/personalizing-care-within-the-rcc-treatment-paradigm/29528/Our experts discuss risk stratification, the latest clinical evidence & personalized, multidisciplinary strategies in advanced RCC care.New Drug Approved for PPD: Solving an Unmet Need
https://reachmd.com/programs/neurofrontiers/new-drug-approved-for-ppd-solving-an-unmet-need/15897/Postpartum depression is a mood disorder that can occur after childbirth and affects around 15 percent of new mothers.